The BioFocus website uses cookies to store information on your computer, to improve our website. One of the cookies we use is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies we use and how to delete them, see our privacy notice.

I accept cookies from this site
 

Offerings

BioFocus provides integrated drug discovery that delivers pre-clinical drug candidates in all therapeutic areas with strong capability in neurodegenerative diseases, inflammatory diseases and with a growing track record of delivering candidates against rare and neglected diseases.

News, events and newsletters Subscribe to the RSS feed

view all news, events and newsletters

ADME/PK

Automated patch-clamp assay for assessment of hERG liability. Using our electrophysiology expertise, BioFocus has validated a hERG inhibition assay combining the IonWorks® Quattro™ automated electrophysiology platform, with the PrecisION™ hERG-HEK recombinant cell line from Millipore.
Contact us now for a quotation.


BioFocus®, SoftFocus®, Galapagos®, SilenceSelect® and FLeXSelect® ThemePair™, FieldFocus™, HDRA™. Helical Domain Recognition Analysis™, 2D Roadmap™, Thematic Analysis™, SFK™, SFI™, SFG™ and PrimePath™ are trademarks of Galapagos NV and/or its affiliates.